| Status: Medicine does not meet criteria for AWMSG assessment | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA991: Abaloparatide for treating osteoporosis after menopause |
|
Medicine details |
|
| Medicine name | abaloparatide |
| Formulation | transdermal patch |
| Reference number | 3204 |
| Indication | Treatment of osteoporosis in postmenopausal women |
| Company | Radius Health Inc |
| BNF chapter | Endocrine system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/03/2023 |
| NICE guidance | TA991: Abaloparatide for treating osteoporosis after menopause |